External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ATS 2021

-
Coming soon
10:10 AM
Duration 3mins Virtual
Tocilizumab in Systemic Sclerosis Interstitial Lung Disease: Safety and Efficacy in the Double-Blind and Open-Label Periods of a Randomized Controlled Phase 3 Trial
Dinesh Khanna, MD, Celia J. F. Lin, MD, Daniel E. Furst, MD, Mauro Zucchetto, MS, Ganesh Raghu, MD, Fernando J. Martinez, MD, Christopher P. Denton, FRCP

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar